Compare WVE & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | MLKN |
|---|---|---|
| Founded | 2012 | 1905 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2015 | N/A |
| Metric | WVE | MLKN |
|---|---|---|
| Price | $16.04 | $18.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $29.44 | N/A |
| AVG Volume (30 Days) | ★ 13.6M | 858.2K |
| Earning Date | 11-10-2025 | 12-17-2025 |
| Dividend Yield | N/A | ★ 4.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $109,230,000.00 | ★ $3,748,900,000.00 |
| Revenue This Year | N/A | $5.40 |
| Revenue Next Year | $31.09 | $3.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 103.75 | 4.34 |
| 52 Week Low | $5.28 | $13.77 |
| 52 Week High | $21.73 | $25.65 |
| Indicator | WVE | MLKN |
|---|---|---|
| Relative Strength Index (RSI) | 63.98 | 69.24 |
| Support Level | $15.23 | $16.53 |
| Resistance Level | $17.41 | $19.15 |
| Average True Range (ATR) | 1.83 | 0.63 |
| MACD | 0.22 | 0.31 |
| Stochastic Oscillator | 61.52 | 72.88 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.